These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35218600)

  • 1. Institutional Review Board Use of Outside Experts: What Do We Know?
    Serpico K; Rahimzadeh V; Anderson EE; Gelinas L; Lynch HF
    Ethics Hum Res; 2022 Mar; 44(2):26-32. PubMed ID: 35218600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional Review Board Use of Outside Experts: A National Survey.
    Serpico K; Rahimzadeh V; Gelinas L; Hartsmith L; Lynch HF; Anderson EE
    AJOB Empir Bioeth; 2022; 13(4):251-262. PubMed ID: 35748820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRBs and the Protection-Inclusion Dilemma: Finding a Balance.
    Friesen P; Gelinas L; Kirby A; Strauss DH; Bierer BE
    Am J Bioeth; 2023 Jun; 23(6):75-88. PubMed ID: 35482887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.
    Abbott L; Grady C
    J Empir Res Hum Res Ethics; 2011 Mar; 6(1):3-19. PubMed ID: 21460582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US IRBs confronting research in the developing world.
    Klitzman RL
    Dev World Bioeth; 2012 Aug; 12(2):63-73. PubMed ID: 22515423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.
    Lynch HF; Nicholls S; Meyer MN; Taylor HA;
    J Empir Res Hum Res Ethics; 2019 Jul; 14(3):190-196. PubMed ID: 30541368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors influencing the organizational capacity of Institutional Review Boards In China: a crisp-set Qualitative Comparative Analysis based on 107 cases.
    Lu L; Shi S; Liu B; Liu C
    BMC Med Ethics; 2023 Sep; 24(1):74. PubMed ID: 37749525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emergence of Clinical Research Ethics Consultation: Insights From a National Collaborative.
    Porter KM; Danis M; Taylor HA; Cho MK; Wilfond BS;
    Am J Bioeth; 2018 Jan; 18(1):39-45. PubMed ID: 29313771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.
    Klitzman R
    PLoS One; 2011; 6(7):e22796. PubMed ID: 21829516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process, Power, and Impact of the Institutional Review Board in Criminology and Criminal Justice Research.
    Gunnison E; Helfgott JB
    J Empir Res Hum Res Ethics; 2021 Jul; 16(3):263-279. PubMed ID: 33689486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How good does the science have to be in proposals submitted to Institutional Review Boards? An interview study of Institutional Review Board personnel.
    Klitzman R
    Clin Trials; 2013 Oct; 10(5):761-6. PubMed ID: 24000378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and capacity of Institutional Review Boards, and challenges experienced by members in ethics review processes in Addis Ababa, Ethiopia: An exploratory qualitative study.
    Seralegne YZ; Wangamati CK; Bernabe RDLC; Farsides B; Aseffa A; Zewdie M
    Dev World Bioeth; 2023 Mar; 23(1):50-58. PubMed ID: 35247023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles, challenges and institutionalization of institutional review boards.
    Oyibo WA; Krugher M; Fagbenro-Beyioku AF
    Nig Q J Hosp Med; 2008; 18(2):115-9. PubMed ID: 19068565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empowering local research ethics review of antibacterial mass administration research.
    Sewankambo NK; Kutyabami P
    Infect Dis Poverty; 2022 Sep; 11(1):103. PubMed ID: 36171611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the Single IRB Burden: Streamlining Electronic IRB Systems.
    Murray A; Pivovarova E; Klitzman R; Stiles DF; Appelbaum P; Lidz CW
    AJOB Empir Bioeth; 2021; 12(1):33-40. PubMed ID: 32976069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional Review Boards: Purpose and Challenges.
    Grady C
    Chest; 2015 Nov; 148(5):1148-1155. PubMed ID: 26042632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.